Attention-deficit/hyperactivity disorder in adults: An overview

被引:481
|
作者
Faraone, SV
Biederman, J
Spencer, T
Wilens, T
Seidman, LJ
Mick, E
Doyle, AE
机构
[1] Harvard Univ, Sch Med, Pediat Psychopharmacol Unit, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA USA
关键词
attention-deficit/hyperactivity disorder; diagnostic validity; developmental psychopathology;
D O I
10.1016/S0006-3223(00)00889-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To assess the validity of adult attention-deficit/hyperactivity disorder (ADHD), we reviewed clinical, family, psychopharmacologic, neurobiological, and outcome studies. We found multiple reports describing adults with clinical features highly reminiscent of the childhood ADHD. These adults, who are impulsive, inattentive, and restless, have the clinical "look and feel" of ADHD children. As with their childhood counterparts, many adults with ADHD suffer from antisocial, depressive, and anxiety disorders. They also show clinically significant impairments-histories of school failure, occupational problems, and traffic accidents. Studies of biological features show correspondences between child and adult cases of ADHD, Both show familial aggregation and a characteristic profile of neuropsychologic deficits; an emerging neuroimaging literature suggests that abnormalities in the same brain regions underlie both the child and adult forms of the disorder, Although these converging lines of evidence support the validity of ADHD in adults, follow-up studies of ADHD children have yielded ambiguous results, This ambiguity is in part due to differences in how researchers define the persistence of ADHD, a problem that suggests future research focus on how best to diagnose ADHD in adulthood (C) 2000 Society of Biological Psychiatry.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 50 条
  • [41] RISK OF INJURY IN ADULTS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    Montejano, L. B.
    Sasane, R.
    Hodgkins, P.
    Huse, D.
    VALUE IN HEALTH, 2009, 12 (03) : A174 - A174
  • [42] Psychosocial treatments for adults with attention-deficit/hyperactivity disorder
    Safren, SA
    Sprich, S
    Chulvick, S
    Otto, MW
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 27 (02) : 349 - +
  • [43] Lisdexamfetamine DimesylateIn Attention-Deficit Hyperactivity Disorder in Adults
    Juliane Weber
    M. Asif A. Siddiqui
    CNS Drugs, 2009, 23 : 419 - 425
  • [44] Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Adults
    Post, Robert E.
    Kurlansik, Stuart L.
    AMERICAN FAMILY PHYSICIAN, 2012, 85 (09) : 890 - 896
  • [45] Quantitative EEG in adults with attention-deficit/hyperactivity disorder
    Czobor, Pal
    Simon, Viktoria
    Tombor, Laszlo
    Papp, Szilvia
    Komlosi, Sarolta
    Kakuszi, Brigitta
    Szuromi, Balint
    Balogh, Livia
    Angyalosi, Anna
    Kovacs, Dora
    Bitter, Istvan
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2010, 77 (03) : 249 - 249
  • [46] Adults with attention-deficit hyperactivity disorder - diagnosis or normality?
    Shah, Premal J.
    Morton, Michael J. S.
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (05) : 317 - 319
  • [47] The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults
    Breda, Vitor
    Rohde, Luis Augusto
    Baptista Menezes, Ana Maria
    Anselmi, Luciana
    Caye, Arthur
    Rovaris, Diego Luiz
    Vitola, Eduardo Schneider
    Dotto Bau, Claiton Henrique
    Grevet, Eugenio Horacio
    BRITISH JOURNAL OF PSYCHIATRY, 2021, 218 (01) : 43 - 50
  • [48] Disentangling deficits in adults with attention-deficit/hyperactivity disorder
    Bekker, EM
    Overtoom, CCE
    Kooij, JJS
    Buitelaar, JK
    Verbaten, MN
    Kenemans, JL
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (10) : 1129 - 1136
  • [49] Pharmacological treatment of attention-deficit/hyperactivity disorder in adults
    Slatkoff, Joshua
    Greenfield, Brian
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (06) : 649 - 667
  • [50] Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder
    Timothy E. Wilens
    Drugs, 2003, 63 : 2395 - 2411